Exelixis

[video] The Next Big Thing In Biotech: Exelixis
TheStreet.com
Fri, 09/2/11 - 02:15 pm
Exelixis
Exelixis: Still Promising, Still Controversial
Seeking Alpha
Mon, 08/22/11 - 11:47 am
Exelixis
cabozantinib
Bone metastases
Biotech Gem Exelixis Is Compelling Only for the Long Term
Seeking Alpha
Sat, 08/20/11 - 10:03 pm
Exelixis
cabozantinib
XL184
10 Biotech Takeover/LBO Targets With Bullish Options Sentiment
Seeking Alpha
Thu, 07/21/11 - 12:21 pm
M&A
Chelsea Therapeutics
Amgen
Human Genome Sciences
Acorda Therapeutics
Celgene
Dendreon
InterMune
Biomarin
Alnylam
Exelixis
The Tale of 2 Drug Handbacks
Motley Fool
Mon, 07/18/11 - 05:33 pm
Exelixis
Bristol-Myers Squibb
cabozantinib
XL-281
5 Biotech Takeover / LBO Targets With Bullish Short Trends
Seeking Alpha
Sat, 07/16/11 - 11:39 am
Exelixis
InterMune
Dendreon
Savient
Acorda Therapeutics
The Good, Bad, and Ugly of Exelixis' Drug Delay
Motley Fool
Thu, 07/7/11 - 10:11 pm
Exelixis
thyroid cancer
cabozantinib
Exelixis Delays Results of Cancer Drug Study
Minyanville
Thu, 07/7/11 - 12:06 pm
Exelixis
cabozantinib
thyroid cancer
Should Biotech Investors Go Where Institutions Won't?
Investopedia
Thu, 07/7/11 - 12:04 pm
investors
biotech
Aeterna Zentaris
YM BioSciences
Ziopharm
Oncothyreon
Seattle Genetics
Exelixis
MannKind
MELA Sciences
Neoprobe
Zalicus
10 Biotech Trades for Second Half of 2011
TheStreet.com
Wed, 07/6/11 - 08:51 am
Sangamo BioSciences
BioSante
Seattle Genetics
YM BioSciences
Exelixis
Transcept
Oncothyreon
Gilead Sciences
Medivation
Neoprobe
After the breakup: the end of a partnership with big pharma brings both opportunity and challenge for biotech firms
Chemical and Engineering News
Fri, 06/24/11 - 10:17 am
Exelixis
Bristol-Myers Squibb
Vertex: First Drugs Ever to Target Root Cause of Cystic Fibrosis
Seeking Alpha
Mon, 06/13/11 - 06:09 pm
Vertex Pharmaceuticals
cystic fibrosis
CF
VX-770
Exelixis
Exelixis, YM Biosciences Lead Losers at Cancer Meeting
Minyanville
Sat, 06/11/11 - 10:22 am
Exelixis
YM BioSciences
A Dull ASCO And The Usual Sell-Off
Investopedia
Tue, 06/7/11 - 07:34 pm
ASCO
Celgene
Bristol-Myers Squibb
Incyte
Exelixis
Novartis
YM BioSciences
Neoprobe
ASCO studies shake up drug stocks
Marketwatch
Tue, 06/7/11 - 06:22 pm
ASCO
drug stocks
Sunesis
Exelixis
Bayer
Oxigene
Regeneron
EntreMed
ASCO '11: Exelixis Updates Prostate Cancer Data
TheStreet.com
Mon, 06/6/11 - 09:28 pm
Exelixis
prostate cancer
ASCO
cabozantinib
Exelixis Drug Shrinks Ovarian Cancer
The Street
Sun, 06/5/11 - 10:06 am
Exelixis
cabozantinib
ovarian cancer
5 Biotechs With Upcoming Clinical Trial Results
Motley Fool
Wed, 06/1/11 - 07:52 am
Amarin
AMR101
cabozantinib
Exelixis
HIV quad pill
Gilead Sciences
Medivation
MDV3100
Astellas
Vical
skin cancer
YM BioSciences
nimotuzumab
The Biggest Gift Biotechs Can Give to Investors
Motley Fool
Tue, 05/31/11 - 12:36 pm
investors
biotech
Vertex Pharmaceuticals
Exelixis
CytRx
GSK
Novavax
JNJ
Pfizer
Biogen Idec
Seattle Genetics
Immunogen
Alnylam
4 Biotech Stocks That Could Pop
Seeking Alpha
Thu, 05/19/11 - 02:05 pm
Celsion
Exelixis
Savient
Amag Pharmaceuticals

Pages